bmiMD vs FuturHealth (2026): Compounded GLP-1 Clinic Comparison
bmiMD and FuturHealth are two of the most-searched budget GLP-1 telehealth platforms in 2026. Both offer compounded semaglutide and tirzepatide at competitive prices, but they differ significantly in coaching depth, brand-name access, and how their subscription tiers are structured. bmiMD is a lean, medication-focused clinic with transparent tiered pricing; FuturHealth bundles weekly coaching and nutrition support into a flat $198/mo subscription that includes medication access.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
BMI Doctor and FuturHealth are both GLP-1 platforms, but FuturHealth has a broader multi-category offering that includes brand-name GLP-1 access alongside compounded options. BMI Doctor is a compounded-only specialist that competes primarily on price.
FuturHealth's brand-name access is a genuine advantage for patients who want the option to transition from compounded to brand-name Wegovy or Zepbound as their insurance situation changes. BMI Doctor is more competitive on price for compounded-only protocols. The choice depends on whether brand-name access matters to you — if it does, FuturHealth is worth the price premium.
bmiMD
Plan-length-priced compounded semaglutide with optional longevity add-ons and online clinician access.
FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Side-by-Side Comparison
| Attribute | bmiMD | FuturHealth |
|---|---|---|
| Program Fee | Included in observed semaglutide plan price | Included in monthly plan |
| Medication From | From $99 – $129/mo | From $198 – $395/mo |
| Editor Score | 4.7 / 5 | 4.0 / 5 |
| Primary Category | GLP-1 Weight Loss | GLP-1 Weight Loss |
| FDA Brand-Name Access | Wegovy, Zepbound, Ozempic, Mounjaro | Wegovy, Zepbound, Ozempic, Mounjaro |
| Compounded Options | 2 compounds | 1 compounds |
| Adjacent Categories | GLP-1 Weight Loss |
The Verdict
Choose bmiMD if you want the lowest-cost compounded GLP-1 with minimal overhead: their entry plans start below $150/mo and there is no mandatory coaching layer. Choose FuturHealth if you want brand-name GLP-1 access (Wegovy, Zepbound, Ozempic, Mounjaro), the oral Wegovy pill, or a structured coaching program bundled with medication for a flat fee.
Frequently Asked Questions
Is bmiMD or FuturHealth cheaper?
bmiMD's entry compounded semaglutide plan starts lower than FuturHealth's flat $198/mo. However, FuturHealth's $198/mo includes weekly coaching and nutrition support that bmiMD charges separately, so the all-in cost comparison depends on how much support you want.
Does FuturHealth offer brand-name GLP-1?
Yes, FuturHealth offers Wegovy, Zepbound, Ozempic, and Mounjaro at clinic-published rates on top of the base subscription. bmiMD focuses primarily on compounded semaglutide and tirzepatide.
Does bmiMD raise prices as you titrate?
bmiMD uses tiered pricing where higher-dose vials cost more. The monthly cost increases as you move from starter doses to maintenance doses, which is standard across most compounded GLP-1 platforms.
Which has better reviews?
Both platforms have strong Trustpilot scores. bmiMD has accumulated more reviews given its longer operating history; FuturHealth's reviews emphasize the coaching team quality.